Stroke
Conditions
Brief summary
To collect large-scale, high-quality clinical data, daily activity and movement patterns, and genomic information from stroke patients spanning the subacute to chronic stages. This study aims to establish the foundation for personalized precision medicine in stroke care and to develop a visual and digital transformation of patient medical information in the era of digital healthcare.
Detailed description
This study aims to establish a comprehensive, high-quality dataset that captures the longitudinal characteristics of stroke recovery from the subacute to chronic stages. By integrating clinical data, daily activity and movement patterns, and genomic information, the study reflects the multidimensional nature of stroke in a real-world setting. The collected data will support data-driven approaches in stroke care by enabling a better understanding of individual variability in recovery trajectories and facilitating the development of predictive models for functional outcomes. In addition, this study seeks to contribute to personalized precision medicine by enabling individualized interpretation of patient data. It also supports the digital transformation of healthcare by facilitating structured, visual, and data-driven representations of patient medical information for improved clinical and research applications.
Interventions
OTHERStroke
No intervention
Sponsors
Seyoung Shin
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults aged 20 years or older with a confirmed diagnosis of stroke. * Within 1 month after stroke onset. * Patients scoring between 0 and 3 points on the Functional Ambulatory Category (FAC) test. * Patients or their legally authorized representatives who have fully understood the details of this study, voluntarily decided to participate, and provided written informed consent to comply with the study instructions.
Exclusion criteria
* Patients with impaired ability to provide consent (MMSE score less than 10) who are not accompanied by a caregiver. * Any other cases deemed inappropriate for participation by the investigator. (This study is non-interventional; therefore, patients who are currently participating in or have participated in another clinical study or research within the past 30 days may still be included.)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Modified Barthel Index (MBI) | minimum <1 months to maximum 6 months | A scale to measure disability or dependence in activities of daily living (ADL) of stroke survivors (range 0-100) |
| Mini Mental Status Examination (MMSE) | minimum <1 months to maximum 6 months | Mini-Mental State Examination (MMSE) is a 30-question assessment of cognitive function that evaluates attention and orientation, memory, registration, recall, calculation, language and ability to draw a complex polygon (range 0-30) |
| Functional Ambulatory Category (FAC) | minimum <1 months to maximum 6 months | The Functional Ambulation Categories (FAC) is a 6-point functional walking test that evaluates ambulation ability, determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device. (range 0-5) |
| Fugl-Meyer Assessment (FMA) | minimum <1 months to maximum 6 months | The Fugl-Meyer Assessment (FMA) is a performance-based scale used to evaluate motor functioning, balance, sensation, and joint functioning in patients who have experienced a stroke. The motor domain (score range 0-100) assesses movement, coordination, and reflexes of the upper and lower extremities, with higher scores indicating better motor recovery. |
Countries
South Korea
Contacts
CONTACTSeyoung Shin, MD
PRINCIPAL_INVESTIGATORSeyoung Shin, MD
CHA University
Outcome results
None listed